299 related articles for article (PubMed ID: 17166182)
1. Congenital disorder of glycosylation type Ia: searching for the origin of common mutations in PMM2.
Quelhas D; Quental R; Vilarinho L; Amorim A; Azevedo L
Ann Hum Genet; 2007 May; 71(Pt 3):348-53. PubMed ID: 17166182
[TBL] [Abstract][Full Text] [Related]
2. Lack of Hardy-Weinberg equilibrium for the most prevalent PMM2 mutation in CDG-Ia (congenital disorders of glycosylation type Ia).
Schollen E; Kjaergaard S; Legius E; Schwartz M; Matthijs G
Eur J Hum Genet; 2000 May; 8(5):367-71. PubMed ID: 10854097
[TBL] [Abstract][Full Text] [Related]
3. A new insight into PMM2 mutations in the French population.
Le Bizec C; Vuillaumier-Barrot S; Barnier A; Dupré T; Durand G; Seta N
Hum Mutat; 2005 May; 25(5):504-5. PubMed ID: 15844218
[TBL] [Abstract][Full Text] [Related]
4. Functional analysis of three splicing mutations identified in the PMM2 gene: toward a new therapy for congenital disorder of glycosylation type Ia.
Vega AI; Pérez-Cerdá C; Desviat LR; Matthijs G; Ugarte M; Pérez B
Hum Mutat; 2009 May; 30(5):795-803. PubMed ID: 19235233
[TBL] [Abstract][Full Text] [Related]
5. Characterization of two unusual truncating PMM2 mutations in two CDG-Ia patients.
Schollen E; Keldermans L; Foulquier F; Briones P; Chabas A; Sánchez-Valverde F; Adamowicz M; Pronicka E; Wevers R; Matthijs G
Mol Genet Metab; 2007 Apr; 90(4):408-13. PubMed ID: 17307006
[TBL] [Abstract][Full Text] [Related]
6. PMM2 intronic branch-site mutations in CDG-Ia.
Vuillaumier-Barrot S; Le Bizec C; De Lonlay P; Madinier-Chappat N; Barnier A; Dupré T; Durand G; Seta N
Mol Genet Metab; 2006 Apr; 87(4):337-40. PubMed ID: 16376131
[TBL] [Abstract][Full Text] [Related]
7. Mutations in PMM2 that cause congenital disorders of glycosylation, type Ia (CDG-Ia).
Matthijs G; Schollen E; Bjursell C; Erlandson A; Freeze H; Imtiaz F; Kjaergaard S; Martinsson T; Schwartz M; Seta N; Vuillaumier-Barrot S; Westphal V; Winchester B
Hum Mutat; 2000 Nov; 16(5):386-94. PubMed ID: 11058895
[TBL] [Abstract][Full Text] [Related]
8. PMM2 mutation spectrum, including 10 novel mutations, in a large CDG type 1A family material with a focus on Scandinavian families.
Bjursell C; Erlandson A; Nordling M; Nilsson S; Wahlström J; Stibler H; Kristiansson B; Martinsson T
Hum Mutat; 2000 Nov; 16(5):395-400. PubMed ID: 11058896
[TBL] [Abstract][Full Text] [Related]
9. Biochemical and molecular studies in 26 Spanish patients with congenital disorder of glycosylation type Ia.
Briones P; Vilaseca MA; Schollen E; Ferrer I; Maties M; Busquets C; Artuch R; Gort L; Marco M; van Schaftingen E; Matthijs G; Jaeken J; Chabás A
J Inherit Metab Dis; 2002 Dec; 25(8):635-46. PubMed ID: 12705494
[TBL] [Abstract][Full Text] [Related]
10. The Effects of PMM2-CDG-Causing Mutations on the Folding, Activity, and Stability of the PMM2 Protein.
Yuste-Checa P; Gámez A; Brasil S; Desviat LR; Ugarte M; Pérez-Cerdá C; Pérez B
Hum Mutat; 2015 Sep; 36(9):851-60. PubMed ID: 26014514
[TBL] [Abstract][Full Text] [Related]
11. Congenital disorder of glycosylation type Ia: a clinicopathological report of a newborn infant with cerebellar pathology.
Aronica E; van Kempen AA; van der Heide M; Poll-The BT; van Slooten HJ; Troost D; Rozemuller-Kwakkel JM
Acta Neuropathol; 2005 Apr; 109(4):433-42. PubMed ID: 15714316
[TBL] [Abstract][Full Text] [Related]
12. PMM2-CDG: phenotype and genotype in four affected family members.
Bortot B; Cosentini D; Faletra F; Biffi S; De Martino E; Carrozzi M; Severini GM
Gene; 2013 Dec; 531(2):506-9. PubMed ID: 23988505
[TBL] [Abstract][Full Text] [Related]
13. Targeted disruption of the mouse phosphomannomutase 2 gene causes early embryonic lethality.
Thiel C; Lübke T; Matthijs G; von Figura K; Körner C
Mol Cell Biol; 2006 Aug; 26(15):5615-20. PubMed ID: 16847317
[TBL] [Abstract][Full Text] [Related]
14. [Molecular diagnosis of congenital disorders of glycosylation].
Vuillaumier-Barrot S
Ann Biol Clin (Paris); 2005; 63(2):135-43. PubMed ID: 15771971
[TBL] [Abstract][Full Text] [Related]
15. Congenital disorder of glycosylation type 1a: three siblings with a mild neurological phenotype.
Coman D; McGill J; MacDonald R; Morris D; Klingberg S; Jaeken J; Appleton D
J Clin Neurosci; 2007 Jul; 14(7):668-72. PubMed ID: 17451957
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the 415G>A (E139K) PMM2 mutation in carbohydrate-deficient glycoprotein syndrome type Ia disrupting a splicing enhancer resulting in exon 5 skipping.
Vuillaumier-Barrot S; Barnier A; Cuer M; Durand G; Grandchamp B; Seta N
Hum Mutat; 1999 Dec; 14(6):543-4. PubMed ID: 10571956
[TBL] [Abstract][Full Text] [Related]
17. Absence of homozygosity for predominant mutations in PMM2 in Danish patients with carbohydrate-deficient glycoprotein syndrome type 1.
Kjaergaard S; Skovby F; Schwartz M
Eur J Hum Genet; 1998; 6(4):331-6. PubMed ID: 9781039
[TBL] [Abstract][Full Text] [Related]
18. Hydrophobic Man-1-P derivatives correct abnormal glycosylation in Type I congenital disorder of glycosylation fibroblasts.
Eklund EA; Merbouh N; Ichikawa M; Nishikawa A; Clima JM; Dorman JA; Norberg T; Freeze HH
Glycobiology; 2005 Nov; 15(11):1084-93. PubMed ID: 16079417
[TBL] [Abstract][Full Text] [Related]
19. Detailed mapping of the phosphomannomutase 2 (PMM2) gene and mutation detection enable improved analysis for Scandinavian CDG type I families.
Bjursell C; Wahlström J; Berg K; Stibler H; Kristiansson B; Matthijs G; Martinsson T
Eur J Hum Genet; 1998; 6(6):603-11. PubMed ID: 9887379
[TBL] [Abstract][Full Text] [Related]
20. Identification of a IVS4-58delATG polymorphism in the human phosphomannomutase 2 (PMM2) gene.
Vuillaumier-Barrot S; Bizec CL; Durand G; Grandchamp B; Seta N
Hum Mutat; 2000 May; 15(5):486. PubMed ID: 10790224
[No Abstract] [Full Text] [Related]
[Next] [New Search]
